PTC Therapeutics Says European Commission Returns Translarna Opinion To CHMP For Re-evaluation

RTTNews | 867 hari yang lalu
PTC Therapeutics Says European Commission Returns Translarna Opinion To CHMP For Re-evaluation

(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Monday that the European Commission (EC) has decided not to adopt the CHMP's negative opinion of January 24, 2024 on the annual renewal of the conditional marketing authorization of Translarna (ataluren) and has returned the opinion to the CHMP for re-evaluation.

As a result, Translarna remains on the market and available for patients in Europe consistent with its current marketing authorization. The EC has asked the CHMP to further consider the totality of evidence, including data from patient registries and real-world evidence, in a revised opinion.

In addition, the European Medicines Agency (EMA) has informed PTC that the decision has been taken to consider the Scientific Advisory Group (SAG) meeting for Translarna held on September 5, 2023, and all the procedural steps that followed, as invalid.

Furthermore, the input from the SAG meeting held in September 2023 as well as the meeting held in January 2024 will not be considered by the CHMP in any future evaluation of Translarna.

Given the inability to accurately forecast the upside impact of the continued authorization of Translarna in Europe on 2024 revenue, PTC will pause 2024 total revenue guidance at this time.

baca selengkapnya
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | 688 hari yang lalu
PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

PTC Therapeutics, Inc. (PTCT) announced Wednesday that Upstaza (eladocagene exuparvovec) was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older.
RTTNews | 1537 hari yang lalu
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

Save for a few minutes at the start, the Switzerland market's benchmark index SMI stayed positive on Friday as lower oil prices and bond yields helped underpin sentiment. Additionally, weaker than expected jobs data from the U.S. has somewhat reduced the likelihood of the Federal Reserve raising interest rates at its next meeting later this month.
RTTNews | 1 hari yang lalu
Canadian Market Remains Firmly Up In Positive Territory

Canadian Market Remains Firmly Up In Positive Territory

The Canadian market is up firmly in positive territory around noon on Friday thanks to weak oil prices and lower bond yields aiding sentiment. Additionally, weaker than expected jobs data from the U.S. has somewhat reduced the likelihood of the Federal Reserve raising interest rates at its next meeting later this month.
RTTNews | 1 hari yang lalu
U.S. Factory Orders Inch Up In Line With Estimates In August

U.S. Factory Orders Inch Up In Line With Estimates In August

A report released by the Commerce Department on Friday showed a slight uptick in new orders for U.S. manufactured goods in the month of August. The Commerce Department said factory orders crept up by 0.1 percent in August after climbing by a downwardly revised 0.8 percent in July.
RTTNews | 1 hari yang lalu
U.S. Employment Rises By 29,000 Jobs In September, Much Less Than Expected

U.S. Employment Rises By 29,000 Jobs In September, Much Less Than Expected

The Labor Department released a closely watched report on Friday showing employment in the U.S. increased by much less than expected in the month of September. The report said non-farm payroll employment rose by 29,000 jobs in September after jumping by a downwardly revised 133,000 jobs in August. Economists had expected employment to increase by 85,000 jobs.
RTTNews | 1 hari yang lalu
Euro Slides Against Majors

Euro Slides Against Majors

The euro weakened against other major currencies in the European session on Friday.
RTTNews | 1 hari yang lalu